Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

rhenium Re 188 etidronate

A synthetic compound containing the bisphosphonate etidronate (hydroxyethylidene diphosphonate, HEDP) labeled with rhenium Re188, a beta-emitting radioisotope with potential antineoplastic activity. Upon administration, Re-188 etidronate binds to hydroxyapatite in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. The beta-radiation may provide localized anti-tumor radiotoxicity while sparing extramedullary bone marrow tissues.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:188Re-etidronate
188Re-HEDP
Re 188 etidronic acid
Re 188 hydroxyethylidene diphosphonate
Re-188 etidronate
Re-188 HEDP
Re-188 hydroxyethylidene diphosphonate
Re-188etidronate
rhenium Re 188-HEDP
rhenium Re-188 hydroxyethylidene diphosphonate
rhenium-188 etidronate
rhenium-188 HEDP
rhenium-188-HEDP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search